Ping An Biomedical Co., Ltd. - Class A (PASW) share price
Ping An Biomedical Co., Ltd. - Class A (NASDAQ:PASW) last traded at $1.31, down 17.61% on the day (quote 2026-11-06 21:00 UTC), with a market cap of $0.00B and a 52-week range of $1.07 to $28.56.
| Exchange | NASDAQ |
|---|---|
| Currency | USD |
| Last price | $1.31 |
| 1-day move | -17.61% |
| 52-week range | $1.07 - $28.56 |
| Market cap | $0.00B |
| From 52-week high | -95.40% |
| Volume vs average | 1.5x |
| Falling Shares risk score | 84/100 (CRITICAL) |
| Country | United States |
Frequently asked questions
Why is Ping An Biomedical Co., Ltd. - Class A falling today?
Ping An Biomedical Co., Ltd. - Class A (NASDAQ:PASW) is down 17.61% at its latest quote and trades 95.4% below its 52-week high, on volume 1.5x its average, at a new 52-week low. A price fall alone does not identify a cause: Falling Shares Intelligence links a move to a filing, order or news item only when a source supports it.
What is the Ping An Biomedical Co., Ltd. - Class A share price today?
Ping An Biomedical Co., Ltd. - Class A (NASDAQ:PASW) last traded at $1.31, a -17.61% move on the day as of 2026-11-06 21:00 UTC. Market data comes from public feeds and may be delayed; it is not investment advice.
What is the 52-week range of Ping An Biomedical Co., Ltd. - Class A?
Ping An Biomedical Co., Ltd. - Class A's 52-week low is $1.07 and its 52-week high is $28.56; the shares trade 95.4% below the high.
What is the market cap of Ping An Biomedical Co., Ltd. - Class A?
Ping An Biomedical Co., Ltd. - Class A has a market capitalisation of about $0.00B at the latest price.
What are the risks of investing in Ping An Biomedical Co., Ltd. - Class A?
Falling Shares Intelligence rates Ping An Biomedical Co., Ltd. - Class A 84/100 (CRITICAL) on price stress, volume and disclosure signals. Risk scores are analytical indicators, not allegations or investment advice. Review exchange filings and the company's own disclosures before any decision.
Data is compiled from public exchange feeds and may be delayed. Not investment advice.
Wung Thomas, Editor-in-Chief: wungthomas@fallingshares.com. General enquiries and corrections: info@fallingshares.com